Form 4: Bristol-Myers Squibb Director Acquires Deferred Share Units

Peter J. Arduini, a director of Bristol-Myers Squibb, acquired deferred share units convertible to common stock on September 30, 2024.

Summary

• On September 30, 2024, Peter J. Arduini, a director at Bristol-Myers Squibb, acquired 652.3 deferred share units.
• These units will convert into shares of common stock upon settlement, which occurs when Arduini ceases to be a director or at a previously specified future date.
• The price of the deferred share units was $51.74.
• Following the transaction, Arduini beneficially owns 55,577.675 shares of common stock, including deferred compensation and reinvested dividends.

Sentiment

Score: 5

Explanation: This is a neutral filing reflecting a standard transaction related to director compensation. It doesn't inherently indicate positive or negative sentiment.

Future Outlook

The deferred share units will be converted into common stock upon settlement when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

Industry Context

Form 4 filings are standard practice for company insiders (directors, officers, and 10% owners) to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• The transaction increases the director's stake in the company, aligning their interests with those of shareholders.

Key Dates